{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:51:48Z","timestamp":1762980708981},"reference-count":48,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The clinical manifestations of inherited susceptibility to leukemia encompass a wide phenotypic range, including patients with certain congenital anomalies or early-onset myelodysplastic syndrome (MDS) and some with no obvious medical problems until they develop leukemia. Leukemia susceptibility syndromes occur as a result of autosomal dominant, autosomal recessive, or X-linked recessive inheritance, or de novo occurrence, of germline pathogenic variants in DNA repair, ribosome biogenesis, telomere biology, hematopoietic transcription factors, tumor suppressors, and other critical cellular processes. Children and adults with cytopenias, MDS, dysmorphic features, notable infectious histories, immunodeficiency, certain dermatologic findings, lymphedema, unusual sensitivity to radiation or chemotherapy, or acute leukemia with a family history of early-onset cancer, pulmonary fibrosis, or alveolar proteinosis should be thoroughly evaluated for a leukemia susceptibility syndrome. Genetic testing and other diagnostic modalities have improved our ability to identify these patients and to counsel them and their family members for subsequent disease risk, cancer surveillance, and therapeutic interventions. Herein, the leukemia susceptibility syndromes are divided into 3 groups: (1) those associated with an underlying inherited bone marrow failure syndrome, (2) disorders in which MDS precedes leukemia development, and (3) those with a risk primarily of leukemia. Although children are the focus of this review, it is important for clinicians to recognize that inherited susceptibility to cancer can present at any age, even in older adults; genetic counseling is essential and prompt referral to experts in each syndrome is strongly recommended.<\/jats:p>","DOI":"10.1182\/asheducation-2017.1.242","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T22:13:11Z","timestamp":1555452791000},"page":"242-250","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Pediatric leukemia susceptibility disorders: manifestations and management"],"prefix":"10.1182","volume":"2017","author":[{"given":"Lisa J.","family":"McReynolds","sequence":"first","affiliation":[{"name":"Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon A.","family":"Savage","sequence":"additional","affiliation":[{"name":"Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111707330152300_B1","article-title":"Fanconi anemia","volume-title":"GeneReviews","author":"Mehta","year":"1993"},{"issue":"6","key":"2019111707330152300_B2","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/ajmg.a.37637","article-title":"Thinking of VACTERL-H? Rule out Fanconi anemia according to PHENOS","volume":"170","author":"Alter","year":"2016","journal-title":"Am J Med Genet A"},{"issue":"7","key":"2019111707330152300_B3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ajh.24373","article-title":"Somatic, hematologic phenotype, long-term outcome, and effect of hematopoietic stem cell transplantation. An analysis of 97 Fanconi anemia patients from the Italian national database on behalf of the Marrow Failure Study Group of the AIEOP (Italian Association of Pediatric Hematology-Oncology)","volume":"91","author":"Svahn","year":"2016","journal-title":"Am J Hematol"},{"issue":"3-4","key":"2019111707330152300_B4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.beha.2014.10.002","article-title":"Fanconi anemia and the development of leukemia","volume":"27","author":"Alter","year":"2014","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"2019111707330152300_B5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3324\/haematol.12234","article-title":"Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry","volume":"93","author":"Rosenberg","year":"2008","journal-title":"Haematologica"},{"issue":"8","key":"2019111707330152300_B6","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3324\/haematol.2009.018119","article-title":"Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry","volume":"95","author":"Tamary","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"2019111707330152300_B7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.2010.08212.x","article-title":"Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study","volume":"150","author":"Alter","year":"2010","journal-title":"Br J Haematol"},{"issue":"8","key":"2019111707330152300_B8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/15476286.2015.1094596","article-title":"The molecular genetics of the telomere biology disorders","volume":"13","author":"Bertuch","year":"2016","journal-title":"RNA Biol"},{"key":"2019111707330152300_B9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/B978-0-12-397898-1.00002-5","article-title":"Human telomeres and telomere biology disorders","volume":"125","author":"Savage","year":"2014","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2019111707330152300_B10","article-title":"Dyskeratosis congenita","volume-title":"GeneReviews","author":"Savage","year":"1993"},{"issue":"3","key":"2019111707330152300_B11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2011.055269","article-title":"Telomere length is associated with disease severity and declines with age in dyskeratosis congenita","volume":"97","author":"Alter","year":"2012","journal-title":"Haematologica"},{"issue":"26","key":"2019111707330152300_B12","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1182\/blood-2008-12-192880","article-title":"Cancer in dyskeratosis congenita","volume":"113","author":"Alter","year":"2009","journal-title":"Blood"},{"key":"2019111707330152300_B13","article-title":"Shwachman-Diamond syndrome","volume-title":"GeneReviews","author":"Myers","year":"1993"},{"issue":"4","key":"2019111707330152300_B14","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jpeds.2013.11.039","article-title":"Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry","volume":"164","author":"Myers","year":"2014","journal-title":"J Pediatr"},{"key":"2019111707330152300_B15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.2011.06349.x","article-title":"Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome","volume":"1242","author":"Dror","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"2019111707330152300_B16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/jmedgenet-2016-104366","article-title":"Mutations in EFL1, an SBDS partner, are associated with infantile pancytopenia, exocrine pancreatic insufficiency and skeletal anomalies in a Shwachman-Diamond like syndrome","volume":"54","author":"Stepensky","year":"2017","journal-title":"J Med Genet"},{"issue":"11","key":"2019111707330152300_B17","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1182\/blood-2016-08-735431","article-title":"Biallelic mutations in DNAJC21 cause Shwachman-Diamond syndrome","volume":"129","author":"Dhanraj","year":"2017","journal-title":"Blood"},{"issue":"9","key":"2019111707330152300_B18","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3324\/haematol.2011.057489","article-title":"Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome","volume":"97","author":"Donadieu","year":"2012","journal-title":"Haematologica"},{"key":"2019111707330152300_B19","article-title":"Diamond-Blackfan anemia","volume-title":"GeneReviews","author":"Clinton","year":"1993"},{"issue":"3","key":"2019111707330152300_B20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1586\/17474086.2014.897923","article-title":"Diamond Blackfan anemia: a model for the translational approach to understanding human disease","volume":"7","author":"Vlachos","year":"2014","journal-title":"Expert Rev Hematol"},{"issue":"23","key":"2019111707330152300_B21","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1182\/blood-2017-01-760462","article-title":"Molecular convergence in ex vivo models of Diamond-Blackfan anemia","volume":"129","author":"O\u2019Brien","year":"2017","journal-title":"Blood"},{"issue":"16","key":"2019111707330152300_B22","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood-2011-08-375972","article-title":"Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry","volume":"119","author":"Vlachos","year":"2012","journal-title":"Blood"},{"key":"2019111707330152300_B23","author":"Vlachos","year":"2016"},{"issue":"15","key":"2019111707330152300_B24","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","article-title":"Role of RUNX1 in hematological malignancies","volume":"129","author":"Sood","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2019111707330152300_B25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet"},{"key":"2019111707330152300_B26","author":"Schlegelberger","year":"2017"},{"issue":"15","key":"2019111707330152300_B27","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood-2016-09-687889","article-title":"GATA factor mutations in hematologic disease","volume":"129","author":"Crispino","year":"2017","journal-title":"Blood"},{"issue":"6","key":"2019111707330152300_B28","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2019111707330152300_B29","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1182\/blood-2011-08-374363","article-title":"Loss-of-function germline GATA2 mutations in patients with MDS\/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature","volume":"119","author":"Kazenwadel","year":"2012","journal-title":"Blood"},{"key":"2019111707330152300_B30","author":"Townsely","year":"2012"},{"issue":"11","key":"2019111707330152300_B31","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"issue":"23","key":"2019111707330152300_B32","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa041331","article-title":"Mutation of CEBPA in familial acute myeloid leukemia","volume":"351","author":"Smith","year":"2004","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111707330152300_B33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2141.2007.06909.x","article-title":"Familial myelodysplasia and acute myeloid leukaemia--a review","volume":"140","author":"Owen","year":"2008","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111707330152300_B34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/leu.2016.364","article-title":"Preleukemia: one name, many meanings","volume":"31","author":"Koeffler","year":"2017","journal-title":"Leukemia"},{"issue":"31","key":"2019111707330152300_B35","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2008.16.5563","article-title":"Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia","volume":"26","author":"Pabst","year":"2008","journal-title":"J Clin Oncol"},{"issue":"10","key":"2019111707330152300_B36","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2015-05-647172","article-title":"Disease evolution and outcomes in familial AML with germline CEBPA mutations","volume":"126","author":"Tawana","year":"2015","journal-title":"Blood"},{"issue":"10","key":"2019111707330152300_B37","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ng.2754","article-title":"A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia","volume":"45","author":"Shah","year":"2013","journal-title":"Nat Genet"},{"issue":"10","key":"2019111707330152300_B38","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.2778","article-title":"Germline PAX5 mutations and B cell leukemia","volume":"45","author":"Hyde","year":"2013","journal-title":"Nat Genet"},{"key":"2019111707330152300_B39","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.14694\/EdBook_AM.2014.34.e44","article-title":"Predisposition to pediatric and hematologic cancers: a moving target","author":"Malkin","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"3","key":"2019111707330152300_B40","doi-asserted-by":"crossref","first-page":"a026286","DOI":"10.1101\/cshperspect.a026286","article-title":"TP53 mutations in hypodiploid acute lymphoblastic leukemia","volume":"7","author":"Comeaux","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2019111707330152300_B41","doi-asserted-by":"crossref","DOI":"10.1053\/j.seminhematol.2017.04.002","article-title":"Practical considerations for diagnosis and management of patients and carriers","author":"Niemeyer","year":"2017"},{"key":"2019111707330152300_B42","author":"Frohnmayer","year":"2015"},{"key":"2019111707330152300_B43","volume-title":"Dyskeratosis Congenita and Telomere Biology Disorders: Diagnosis and Management Guidelines","author":"Savage","year":"2015"},{"issue":"11","key":"2019111707330152300_B44","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1158\/1078-0432.CCR-17-0428","article-title":"Recommendations for surveillance for children with leukemia-predisposing conditions","volume":"23","author":"Porter","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2019111707330152300_B45","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study","volume":"17","author":"Villani","year":"2016","journal-title":"Lancet Oncol"},{"issue":"10","key":"2019111707330152300_B46","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.bbmt.2016.06.018","article-title":"Preemptive bone marrow transplantation and event-free survival in Fanconi anemia","volume":"22","author":"Khan","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2019111707330152300_B47","author":"Dietz","year":"2017"},{"key":"2019111707330152300_B48"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2017\/1\/242\/1250732\/hem00033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2017\/1\/242\/1250732\/hem00033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T23:32:28Z","timestamp":1721172748000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2017\/1\/242\/21121\/Pediatric-leukemia-susceptibility-disorders"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2017.1.242","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,8]]}}}